An 8-Year-Old with Acute Onset Ataxia
Neurol 99:305-310, McLaren, J.R.,et al, 2022
Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010
Human Botulism Immune Globulin for the Treatment of Infant Botulism
NEJM 354:462-471, Arnon,S.S.,et al, 2006
Childhood-onset Multifocal Motor Neuropathy with Conduction Blocks
Neurol 66:922-924, Moroni,I.,et al, 2006
Clinicopath Conf., Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 348:735-743, Case 6-2003, 2003
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Demyelinative Brainstem Encephalitis Responsive to Intravenous Immunoglobulin Therapy
Pediatrics 104:301-304, Assa,A.,et al, 1999
Therapeutic Plasma Exchange and Intravenous Immunoglobulin for Obsessive-Compulsive Disorder and Tic Disorders in Childhood
Lancet 354:1153-1158, Perlmutter,S.J.,et al, 1999
Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Children
Muscle & Nerve 20:1569-1575997., Simmons,Z.,et al, 1997
Neuroblastoma-Associated Opsoclonus-Myoclonus Treated with IVIgG
J Pediatr 127:328-329, Petruzzi,M.J.&deAlarcon,P.A., 1995
CIDP of Childhood:Treatment with High-Dose Intravenous Immunoglobulin
Neurol 41:828-830, Vedanarayanan,V.V.,et al, 1991
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Progressive Rubella Panencephalitis
NEJM 292:990-993,1023, Townsend,J.,et al, 1975
Chronic Progressive Panencephalitis due to Rubella Virus Simulating Subacute Sclerosing Panencephalitis
NEJM 292:994-998,1023, Weil, M.L.,et al, 1975